Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS

Clinical trial NCT06680752 · RECRUITING

Trial details

NCT number: NCT06680752
Sponsor: ARCE Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, in Relapse Acute Myeloid Leukemia Refractory MDS (Myelodysplastic Syndrome)

Start date: 2025-05-20
Primary completion: 2028-10-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.